Interleukin-20 exacerbates acute hepatitis and bacterial infection by downregulating IκBζ target genes in hepatocytes.

Interleukin-20 exacerbates acute hepatitis and bacterial infection by downregulating IκBζ target genes in hepatocytes.
复制标题

DOI:
10.1016/j.jhep.2021.02.004
复制
发表时间:
2021-07
影响因子:
25.7
通讯作者:
Gao B
Gao B
中科院分区:
医学1区
文献类型:
--
作者:
He Y;Feng D;Hwang S;Mackowiak B;Wang X;Xiang X;Rodrigues RM;Fu Y;Ma J;Ren T;Ait-Ahmed Y;Xu M;Liangpunsakul S;Gao B

文献摘要

参考文献

被引文献

相似文献

白细胞介素-20(IL-20)和IL-22属于IL-10家族。IL-10是一种有据可查的抗炎细胞因子,而IL-22以其上皮保护和抗菌功能而闻名,显示出对器官损伤的巨大治疗潜力;但IL-20的功能在很大程度上仍然未知。产生IL-20敲除(IL 20-/-)小鼠和野生型同窝出生小鼠,并注射伴刀豆球蛋白A(ConA)和肺炎克雷伯氏菌(K. P.)分别诱发急性肝炎和细菌感染。IL 20 −/−小鼠对急性肝炎具有抵抗力,选择性升高肝脏保护细胞因子IL-6水平,而不影响大多数其他细胞因子。IL-20对IL-6的这种选择性抑制是由于IL-20靶向肝细胞产生高水平的IL-6但产生有限数量的其他细胞因子。从机制上讲,IL-20上调NAD(P)H:醌氧化还原酶1(NQO 1)表达,随后促进转录因子IκB β的蛋白降解,导致IκB β依赖性基因II 6以及其他几种IκB β依赖性基因(包括脂质运载蛋白-2(Lcn 2))的选择性下调。鉴于IL-6和LCN 2在限制细菌感染中的重要作用,我们检查了IL-20对细菌感染的影响,发现IL-20 −/−小鼠对K. P.感染具有抗性,同时伴有肝脏IκB β依赖性抗菌基因的升高。此外,IL-20通过与IL-22 R1/IL-20 R2结合激活ERK/p38 MAPK/NRF 2信号通路而上调肝NQO 1。最后,在急性酒精性肝炎患者中,肝脏IL 1 B、IL 20和IκB β靶基因升高并且相互关联。IL-20选择性地抑制肝脏IL-6的产生,而不是发挥IL-10样的广泛抗炎特性,并且与IL-22相比,通过加重急性肝炎和细菌感染而具有相反的功能。因此,抗IL-20治疗可能有助于控制急性肝炎和细菌感染。免疫细胞来源的IL-20通过与IL-22 R1/IL-20 R2结合激活ERK/NRF 2和p38/NRF 2信号通路诱导肝细胞中NQO 1表达。升高的NQO 1促进肝细胞中IκB β降解,随后下调IκB β靶向的肝保护和抗菌基因(例如IL 6和Lcn 2),从而加速急性肝炎和细菌感染。总的来说,IL-20通过下调肝细胞中IκB β靶基因而加重急性肝炎和细菌感染。
Interleukin-20 (IL-20) and IL-22 belong to the IL-10 family. IL-10 is a well-documented anti-inflammatory cytokine while IL-22 is well-known for its epithelial protection and anti-bacterial function, showing great therapeutic potential for organ damage; but the function of IL-20 remains largely unknown. IL-20 knockout (Il20−/−) mice and wild-type littermates were generated and injected with Concanavalin A (ConA) and Klebsiella pneumoniae (K.P.) to induce acute hepatitis and bacterial infection, respectively. Il20−/− mice were resistant to acute hepatitis with selective elevation of the hepatoprotective cytokine IL-6 levels without affecting most other cytokines. Such selective inhibition of IL-6 by IL-20 was due to IL-20 targeting-hepatocytes that produce high levels of IL-6 but a limited number of other cytokines. Mechanistically, IL-20 upregulated NAD(P)H: quinone oxidoreductase 1 (NQO1) expression and subsequently promoted the protein degradation of transcription factor IκBζ, resulting in selective downregulation of the IκBζ-dependent gene Il6 as well several other IκBζ-dependent genes including lipocalin-2 (Lcn2). Given an important role of IL-6 and LCN2 in limiting bacterial infection, we examined the effect of IL-20 on bacterial infection and found Il20−/− mice were resistant to K.P. infection accompanied with an elevation of hepatic IκBζ-dependent antibacterial genes. Moreover, IL-20 upregulated hepatic NQO1 by activating ERK/p38MAPK/NRF2 signaling pathways via the binding of IL-22R1/IL-20R2. Finally, hepatic IL1B, IL20, and IκBζ target genes are elevated and correlated each other in patients with acute alcoholic hepatitis. IL-20 selectively inhibits hepatic IL-6 production rather than exerts an IL-10 like broad anti-inflammatory properties and has opposing functions compared to IL-22 by aggravating acute hepatitis and bacterial infection. Thus, anti-IL-20 therapy may have benefits to control acute hepatitis and bacterial infection. Immune cell-derived IL-20 induces NQO1 expression in hepatocytes by activating ERK/NRF2 and p38/NRF2 signaling pathway via the binding of IL-22R1/IL-20R2. The elevated NQO1 promotes IκBζ degradation in hepatocytes and subsequently downregulates IκBζ-target hepatoprotective and anti-bacterial genes (e.g. Il6 and Lcn2), thereby accelerating acute hepatitis and bacterial infection. Collectively, IL-20 exacerbates acute hepatitis and bacterial infection by downregulating IκBζ-target genes in hepatocytes.
DOI: 10.3389/fimmu.2018.01373
发表时间: 2018
影响因子: 7.3
作者:
Niess JH;Hruz P;Kaymak T
通讯作者: Kaymak T
DOI: 10.1002/hep.31046
发表时间: 2020-04-27
期刊: HEPATOLOGY
影响因子: 13.5
作者:
Arab, Juan P.;Sehrawat, Tejasav S.;Shah, Vijay H.
通讯作者: Shah, Vijay H.
DOI: 10.4049/jimmunol.176.9.5559
发表时间: 2006-05-01
影响因子: 4.4
作者:
Cowland, Jack B.;Muta, Tatsushi;Borregaard, Niels
通讯作者: Borregaard, Niels
DOI: 10.4049/jimmunol.170.10.5252
发表时间: 2003-05-15
影响因子: 4.4
作者:
Ajuebor, MN;Hogaboam, CM;Swain, MG
通讯作者: Swain, MG
DOI: 10.3389/fimmu.2018.01155
发表时间: 2018
影响因子: 7.3
作者:
Caparrós E;Francés R
通讯作者: Francés R